Stent Fracture and Longitudinal Compression on CT Angiography between the

Similar documents
New Generation Drug- Eluting Stent in Korea

PROMUS Element Experience In AMC

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

LM stenting - Cypher

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

PCI for In-Stent Restenosis. CardioVascular Research Foundation

Abstract Background: Methods: Results: Conclusions:

eucalimus - First Experience

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction

The MAIN-COMPARE Study

Left Main Intervention: Will it become standard of care?

Unprotected LM intervention

PCI for Long Coronary Lesion

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

PCI for Left Anterior Descending Artery Ostial Stenosis

The MAIN-COMPARE Registry

DES In-stent Restenosis

Between Coronary Angiography and Fractional Flow Reserve

COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands

What Stent to Use? JASVINDAR SINGH MD, FACC

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery. Christian Seiler No conflict of interest to declare.

Percutaneous Intervention of Unprotected Left Main Disease

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

DIAMOND Study Investigators

Incidence and Treatment for LM In-Stent

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

Basics of Angiographic Interpretation Analysis of Angiography

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Integrated Use of IVUS and FFR for LM Stenting

Alex versus Xience Registry Preliminary report

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

Current DES designs and expansion capacity testing

Incidence and predictors of drug-eluting stent fractures in long coronary disease

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Left Main and Bifurcation Summit I. Lessons from European LM Studies

PCI vs. CABG From BARI to Syntax, Is The Game Over?

DECISION - CTO. optimal Medical Treatment in patients with. Seung-Jung Park, MD, PhD, FACC for the DECISION-CTO Study investigators

Béla MERKELY MD, PhD, DSc, FESC. Stent thrombosis: patophysiology, predisposing factors, definition, classification, prevention and treatment

Important LM bifurcation studies update

Count Down to COMBAT

IVUS vs FFR Debate: IVUS-Guided PCI

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

IN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014

Prognostic Value of Gated Myocardial Perfusion SPECT

Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington.

Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease (BEST Trial)

FFR-guided Jailed Side Branch Intervention

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

Coronary Artery Stenosis. Insight from MAIN-COMPARE Study

DECISION-CTO. Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion. Seung-Jung Park, MD., PhD.

Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Declaration of conflict of interest. Nothing to disclose

Left Main Intervention: Where are we in 2015?

Instantaneous Wave-Free Ratio

Why I try to avoid side branch dilatation

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

LCX. President / Director of Cardiology / New Tokyo Hospital

New Insight about FFR and IVUS MLA

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries

Lessons learned From The National PCI Registry

Bench test : Is it still useful? Do we need standardization?

Jun-Won Lee, Sang Wook Park, Jung-Woo Son, Young Jin Youn, Min-Soo Ahn, Sung Gyun Ahn, Jang-Young Kim, Byung-Soo Yoo, Junghan Yoon, Seung-Hwan Lee

Lessons for technique and stent choice

Upgrade of Recommendation

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

BIOFLOW-III an all comers registry with a Sirolimus Eluting Stent: Presentation of 1-Year TLF Data in patients with complex lesions

PCI for LMCA lesions A Review of latest guidelines and relevant evidence

TRIAL UPDATE 1. ISAR TRIPLE SECURITY Trial. Dr Deven Patel Royal Free Hospital

The SYNTAX-LE MANS Study

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention

high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy

SKG Congress, 2015 EVOLVE II. Stephan Windecker

Non-LM bifurcation studies of importance in 2011

eluting Stents The SPIRIT Trials

The Site of Plaque Rupture in Native Coronary Arteries

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Single Center Consecutive Registry Of The New Atrium Flyer Coronary Stent System

Run-Lin Gao, MD, FACC. On Behalf of I-LOVE-IT Trial Investigators

Drug Eluting Stents: Bifurcation and Left Main Approach

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Prevention of Coronary Stent Thrombosis and Restenosis

Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI

Side Branch Occlusion

CASE from South Korea

Plaque Shift vs. Carina Shift Prevalence and Implication

The BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino

Left main coronary artery (LMCA): The proximal segment

Debate Should we use FFR? I will say NO.

Longitudinal compression of the cobalt-chromium. everolimus-eluting stent during Percutaneous Coronary

Longitudinal distortion of coronary stent in the Left Main Stem: A cautionary tale

Transcription:

2014 ASCI Stent Fracture and Longitudinal Compression on CT Angiography between the First- and New-Generation Drug-Eluting Stent Mi Sun Chung, Dong Hyun Yang,Young-Hak Kim, Jae-Hyung Roh, Joon-Won Kang, Seung-Jung Park, Tae-Hwan Lim et al. Department of Radiology, Division of Cardiology, Heart Institute, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Coronary Stent Fracture Relatively High Incidence Incidence of stent fracture : 1.7 29% Potential Cause of in-stent restenosis (ISR) 20% of the patients with DES ISR have stent fractures Shaikh F, et al. Catheter Cardiovasc Interv 2008;71:614 8 CTA depicts more stent fractures than CAG 16.9% by CTA vs. 1.0% by CAG Hecht HS et al. J Am Coll Cardiol 2009;54:1949 59 Stent Fracture

Definition Longitudinal Compression Distortion or shortening of a stent in the longitudinal axis following successful stent deployment Williams, et al. EuroIntervention, 2012;8: 267-274 New generation drug-eluting stents (DES) Lower longitudinal strength due to thin strut Longitudinal Compression The incidence and clinical significance of longitudinal compression remained unclear

Purpose To evaluate the incidence and clinical impact of stent fracture, longitudinal compression and in-stent restenosis after 1 st - and new generation drug-eluting stent (DES) implantation using CT coronary angiography

Subjects Coronary CT angiography of patients with coronary stent 636 patients May 2011 ~ Feb 2013 Exclusion criteria - No matched coronary angiography (N=188) - Subjects treated with BMS (n=74) 374 patients 1 st generation DES : 235 pts with 368 stents New generation DES : 139 pts with 234 stents

Coronary CTA Imaging Criteria Stent fracture - Partial or circumferential separation of the stent on visual inspection of CT image using Maximal intensity projection (MIP) or curved planar reformation technique (CPR) - Absence of a metallic strut on cross-sectional image Absence of strut Normal strut CPR image MIP image Cross sectional images

Coronary CTA Imaging Criteria Longitudinal compression - Uneven distortion or shortening of a stent in the longitudinal axis - Increased density of a strut in a shorted area

Longitudinal Compression: Phantom validation Resolute Integrity, 3.5 mm CT Cross sectional image Angiography CT Micro-CT

Case 1 Case 1 Stent Fracture and ISR 58 yrs/m with chest pain PCI at prca (Cypher) (2006) Stent fracture causing total occlusion Total occlusion of prca stent was confirmed by angiography _Sudden loss of stent strut _Low density filling defect in stent

Case 2 Longitudinal compression 65 yrs/m PCI at LM-pLAD (Xience prime) (2012-1-11) Longitudinal Compression _osteal lesion CAG (Xience prime) CT _Uneven distortion or shortening of stent in longitudinal axis _Increased density of strut in shorted area

Statistical analysis First- vs. new-generation DES - Pateints demographics - Procedural finding - CTA findings Contingency table between stent fx or longitudinal compression and predisposing factors Morphologic factors of stent Clinical factors Clinical outcomes Kaplan-Mayer curve Log-rank test to compare the difference in clinical outcomes

Baseline Clinical Characteristics Variables 1 st generation DES New generation DES (N=235 patients) (N=139 patients) p value Age, years 60.8 ± 10.2 (34~89) 59.3 ± 10.9 (31~83) 0.19 Male, n (%) 190 (80.9) 105 (75.5) 0.24 BMI (kg/m 2 ) 25.1 ± 2.7 (17.2 ~33.3) 25.1 ± 2.7 (18.9 ~32.1) 0.85 Index diagnosis, n (%) Stable angina 151 (64.3) 83 (59.7) 0.44 Unstable angina 40 (17.0) 33 (23.7) 0.14 Non STEMI 9 (3.8) 8 (5.8) 0.44 STEMI 35 (14.9) 15 (10.8) 0.28 DM, n (%) 65 (27.7) 42 (30.2) 0.64 HTN, n (%) 137 (58.3) 70 (50.4) 0.16 Hyperlipidemia, n (%) 59 (25.1) 66 (47.5) <0.001 Renal failure, n (%) 1 (0.4) 3(2.2) 0.15 Smoking, n (%) 96 (40.9) 51 (36.7) 0.45 LVEF (%) 59.8 ± 7.6 (32.0~79.0) 60.0 ± 6.4 (36.0~72.0) 0.88

Baseline procedural Characteristics Variables 1 st generation DES New generation DES (N=322 stents) (N=213 stents) p value CT findings Long stent 80 (24.8) 60 (28.2) 0.42 Stent overlap 59 (18.3) 48 (44.9) 0.27 Stent in proximal artery 216 (67.1) 150 (70.4) 0.45 Os lesion 18 (5.6) 20 (9.4) 0.12 Stent in excessive tortoursity 22 (6.8) 22 (10.3) 0.15 Underexpansion of stent 19 (5.9) 14 (6.6) 0.86 Angiographic findings Target coronary artery, n (%) LM 18 (7.7) 38 (27.3) < 0.001 LAD 195 (83.0) 112 (80.6) 0.58 LCX 74 (31.5) 53 (38.1) 0.21 RCA 102 (43.4) 63 (45.3) 0.75 Stent diameter (mm) 3.27 ± 0.31 3.31 ± 0.33 0.17 Total stent length (mm) 44.25 ± 27.72 51.72 ± 36.67 0.026 Number of stents 1.71 ± 0.97 2.12 ± 1.38 0.001

Incidence of Fracture, Longitudinal Compression, and In-Stent Restenosis on CT * CTA detected more stent fracture (9.3% vs. 2.3%) and longitudinal compression (2.3% vs. 0.6%) than angiography, respectively. 1 st generation DES (N=322 stents) New generation DES (N=213 stents) p value Stent fracture 26 (8.1) 24 (11.3) 0.23 Longitudinal compression 1 (0.3) 13 (6.1) < 0.001 ISR 14 (4.3) 3 (1.4) 0.08

30 Incidence of Fracture, Longitudinal Compression and ISR on CT according to Stent Type 26.9 25 25 20 19.2 15 10 5 0 8.4 3.8 5.7 8.6 0.3 0 0 0 7.4 10.3 Cypher (n=287) Taxus (n=35) Promus (n=4) Xience or Xience V (n=68) 1.5 10.3 0 2.9 12.5 12.5 6.3 Endeavor (n=68) Resolute (n=16) Xience prime (n=16) 0 0 0 0 0 0 0 Stent fracture Longitudinal compression ISR Promus element (n = 26) Novori or Biomatrix (n=15)

Predisposing factors and stent fracture /longitudinal compression Stent fracture - Longer stent (39 mm vs. 33 mm; p=0.001) - Excessive tortuosity of the stent (25% vs. 8%; p=0.001) - Younger patients (56 yrs vs. 61 yrs; p=0.003) - Stent location (LAD, RCA; p=0.004) Longitudinal compression - Ostial stenting (21.6% vs. 1.2 %; p<0.001) - Stent location (Left main coronary artery; p<0.001)

Clinical outcomes of the patients with 1 st and New generation DES Outcomes 1 st generation DES (N=235 patients) New generation DES (N=139 patients) Fracture or compression Yes (n=23) No (n=212) P value * Yes (n=30) No (n=109) P value * Months 75.3 ± 23.6 84.0 ± 20.7 34.3 ± 16.3 41.0 ± 20.8 Death n (%) 0 1 (0.01) 0.78 0 1 (0.01) 0.60 Cardiac 0 0 0 1 (0.01) 0.60 Non-cardiac 0 1 (0.01) 0.78 0 0 MI, n (%) 0 2 (0.01) 0.66 0 0 TVR, n (%) 3 (0.16) 18 (0.15) 0.25 1 (0.03) 4 (0.04) 0.94 MACE, n(%) 3 (0.16) 20 (0.16) 0.32 1 (0.03) 5 (0.05) 0.77

Conclusions Coronary CTA can evaluate stent fracture and longitudinal compression, in first- and new-generation DES with higher conspicuity than CAG. The risk of longitudinal compression was higher for new-generation DES than for old-generation DES due to thinner struts and fewer connectors. However, fortunately, stent fracture or longitudinal compression did not translate into worse clinical outcomes.

Thank you!